This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Biostratum, Inc., Nephrogenex, Inc. Active years: 2007-2013.
Company Filing History:
Years Active: 2007-2013
Title: The Innovations of Thorsten Degenhardt
Introduction
Thorsten Degenhardt is an accomplished inventor based in Raleigh, NC (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of pyridoxamine. With a total of 2 patents to his name, Degenhardt's work has implications for the treatment and prevention of various health conditions.
Latest Patents
Degenhardt's latest patents focus on non-oxidative methods for the large-scale manufacture of pyridoxamine, a compound known for its potential health benefits. The inventions not only detail the synthesis of pyridoxamine but also provide intermediate compounds and methods for treating conditions associated with the formation of post-Amadori advanced glycation end-products. These advancements highlight his innovative approach to chemical synthesis and its applications in healthcare.
Career Highlights
Throughout his career, Degenhardt has worked with notable companies such as Biostratum, Inc. and Nephrogenex, Inc. His experience in these organizations has allowed him to develop and refine his expertise in the field of medicinal chemistry. His contributions have been instrumental in advancing research and development in the pharmaceutical industry.
Collaborations
Degenhardt has collaborated with esteemed colleagues, including Raja G Khalifah and Christoph Koellner. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thorsten Degenhardt's work exemplifies the spirit of innovation in the field of chemistry. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving health outcomes. His contributions will continue to influence the industry for years to come.